MRIGLOBAL WINS $13.7M NIH/NIAID QUALITY ASSESSMENT CONTRACT FOR MYCOBACTERIUM TUBERCULOSIS
MRIGlobal will evaluate technologies and specimen processes to support the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH) Kansas City, Mo. – MRIGlobal has been awarded a contract (Contract No. HHSN272201700001C)…